Medication info
Diapiryl Tablet 2mg (Glymepiride)

Diapiryl Tablet 2mg (Glymepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Hanin Pharmaceutical Co., Ltd.
Appearance
Green, elongated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200401323 · Approved 2004.01.26 · Insurance code 657200110

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional effect with doses above 4 mg, although some patients have achieved better metabolic control with an increase to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start treatment at 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the efficacy and duration of action of the previously administered medicine. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. In combination therapy with this medicine and metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for glycemic control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
Hanin Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Blood sugar control disorders in patients with type 2 diabetes
View approved original text

This medication helps to improve blood sugar control in patients with type 2 diabetes by complementing diet and exercise therapy. It is typically used alone, but may be combined with insulin or metformin if blood sugar control is insufficient. It is particularly effective when the sulfonylurea or metformin monotherapy does not provide adequate response, enhancing treatment effects when combined. This medication effectively assists patients in managing blood sugar, thereby improving blood sugar control.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional effect with doses above 4 mg, although some patients have achieved better metabolic control with an increase to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start treatment at 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the efficacy and duration of action of the previously administered medicine. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. In combination therapy with this medicine and metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for glycemic control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or those in a comatose state. Individuals allergic to this medication or its components, or to sulfonylureas should not take it. It is advisable to switch severely impaired liver or kidney function patients to insulin therapy instead of using this medication. Pregnant women, women who may become pregnant, and nursing mothers should not take this medication. Patients with severe infections, those undergoing surgery, or those who have suffered serious trauma are recommended to receive insulin therapy. Patients with gastrointestinal disturbances such as diarrhea or vomiting should be cautious, as unsuitable absorption of food may increase the risk of hypoglycemia. For the first week, there is an increased risk of hypoglycemia, so blood sugar levels should be checked frequently and monitored carefully. Special caution is needed for the elderly and those with poor nutritional status, irregular meals, or unbalanced exercise and carbohydrate intake. Those who consume alcohol excessively or skip meals, as well as patients with impaired kidney or liver function, also have an increased risk of hypoglycemia. Additionally, caution is required if this medication is taken in excessive amounts, in cases of endocrine disorders, among elderly patients, or when used in conjunction with other medications. This medication may cause hypoglycemia, with symptoms including headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and loss of consciousness. Hypoglycemia usually recovers quickly with the intake of sugar, so it is important to always carry sugar. Also, vision may become temporarily blurred at first, and gastrointestinal disturbances or liver function impairment, blood disorders, and allergic reactions may occur rarely; consult a doctor immediately if abnormal symptoms arise. When taking this medication, it is necessary to maintain regular intake along with dietary and exercise therapy, and if blood sugar control is inadequate, consult your physician to adjust the treatment regimen. Sufficiently explain the risks and symptoms of hypoglycemia to the patient and their family, and inform any other healthcare provider about diabetes status and medication history when receiving treatment elsewhere. In cases of stress, surgery, or infection that complicates blood sugar control, temporary transition to insulin therapy may be needed. This medication is excreted through the kidneys, so elderly patients or those with reduced kidney function may require dose adjustments. In the case of overdose, severe hypoglycemia may occur, and immediate medical treatment should be sought.

Side effects

Hypoglycemia, headache, intense hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, language impairment, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and damp skin, tachycardia, hypertension, palpitations, angina, arrhythmia, blurred vision, fullness or pressure sensation in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, agranulocytosis, pancytopenia, itching, hives, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, erythema multiforme, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or light, and kept at room temperature between 1 and 30 degrees Celsius. Thus, it is important to store the medication at the appropriate temperature and environment to maintain its efficacy.

Appearance and packaging

Appearance

Green, elongated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.